In the Russian Federation, in 2022, a mass screening of the CFTR gene was conducted among 810 patients aged 2 to 39 years with a diagnosis of “cystic fibrosis caused by a mutation of p.Phe508del in a homozygous state” by MLPA. The gene discussed is CFTR; the disease is cystic fibrosis.